Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS senior advisor joins Alston & Bird

Executive Summary

Centers for Medicare & Medicaid Services Senior Policy Advisor Tim Trysla is joining Alston & Bird's health care practice. Trysla will be rejoining his previous boss, former CMS Administrator Tom Scully (1"The Pink Sheet" Dec. 22, 2004, p. 5)...

You may also be interested in...



OIG counsel joins Alston & Bird

Former HHS Office of Inspector General Senior Counsel Peggy Whitmore joined Alston & Bird's health care practice. Whitmore most recently served in the Industry Guidance Branch at OIG, where her work involved the anti-kickback statute and discounts for uninsured patients. The health care practice includes former Centers for Medicare & Medicaid Services Administrator Tom Scully and former CMS Senior Policy Advisor Tim Trysla (1"The Pink Sheet" April 18, 2005, In Brief)...

Medicare Rx Overseer Will Be CMS Deputy Norwalk; Smith Is Acting CMS Head

The first stages of the implementation of the Medicare prescription drug benefit will be overseen by Centers for Medicare & Medicaid Services acting Deputy Director Leslie Norwalk

CEOs Face Grilling On Vaccine Supply In EU

AstraZeneca's CEO and other leaders from COVID-19 vaccine companies will face some tough questions in Brussels, but the European Commission wants to put differences behind it and solve the vaccine supply problem as soon as possible.

Topics

UsernamePublicRestriction

Register

OM017301

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel